See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Vatican
Olaf Scholz
Volodymyr Zelenskyy
Ukraine War
Donald Trump
Israel-Hamas Conflict
German Politics
Elon Musk
Basketball
Tennis
Hamas
Published • loading... • Updated

Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs

  • Over 100 million Americans viewed Hims & Hers' controversial Super Bowl ad criticizing the weight-loss drug industry, featuring Donald Glover's 'This Is America' as its soundtrack.
  • Several industry groups and lawmakers have labeled the ad as misleading and urged the U.S. Food and Drug Administration to take action against it.
  • Hims & Hers offers compounded semaglutide injections for $199 a month, significantly cheaper than the prices of Ozempic and Wegovy, but these formulations are not FDA-approved.
  • Elizabeth Glowacki, a health communication expert, warns that the ad misleads consumers into thinking they can self-prescribe medication without consulting a doctor, which may lead to harmful consequences.
Insights by Ground AI
Does this summary seem wrong?

11 Articles

All
Left
Center
6
Right
FortuneFortune

Ozempic, Wegovy maker claps back at Hims & Hers Super Bowl ad: ‘Check before you inject’

Compounded weight-loss medications such as those promoted in the Hims & Hers commercial aren’t approved by the Food and Drug Administration.

·New York, United States
Read Full Article
Live ScienceLive Science

Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

·United States
Read Full Article
The Express TribuneThe Express Tribune

Hims & Hers faces backlash over Super Bowl ad for unapproved weight loss drugs

Telehealth company Hims & Hers is under fire for a Super Bowl commercial promoting its compounded versions of weight loss drugs similar to Wegovy and Ozempic.  The ad, which criticizes the U.S. healthcare system, fails to disclose that the drugs are unapproved by the Food and Drug Administration, raising concerns among health experts. Critics argue the ad misleads consumers by omitting crucial safety information typically required in pharmaceuti…

·Pakistan
Read Full Article
AdweekAdweek

Pharma Makes its Mark on the Super Bowl—But Not Without Controversy

Super Bowl LIX ads from Pfizer and Hims & Hers caused backlash. Novartis’ boobs-centric message meanwhile, is resonating with consumers.

Read Full Article
CNBCCNBC

Hims & Hers Super Bowl ad sparks controversy

CNBC's Brandon Gomez joins 'Squawk on the Street' to break down the controversy around Hims & Hers Super Bowl ads.

·United States
Read Full Article
QuartzQuartz

Hims & Hers' off-brand weight loss drugs made a Super Bowl splash. Here's what to know

Over 100 million Americans watched Hims & Hers (HIMS)’ controversial Super Bowl ad taking on the weight-loss drug industry this Sunday during the Super Bowl.Read more...

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Quartz broke the news in United States on Monday, February 10, 2025.
Sources are mostly out of (0)

Similar News Topics

Business

Business

Pharma

Pharma

Wegovy

Wegovy

Obesity

Obesity

FDA

FDA

Super Bowl

Super Bowl

Politics

Politics

News
For You
Search
BlindspotLocal